Zacks' 7 Best Stocks for June, 2013
FREE Report for Zacks.com
Visitors Only

They're hand-picked from the list of Zacks Rank #1 Strong Buys. Our experts predict that their prices will jump the soonest.

Today, you can see them free.

Close This Panel X

Are you a new Zacks Member or a visitor to Zacks.com?

Recent Quotes

No Recent Quote currently available

My Portfolio

My Portfolio Tracker

One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today.

More Zacks Resources

Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.

Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.

Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.

My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.

Zacks #1 Stocks on the Move 05/20/2013

Company Name Symbol %Change
ORBOTECH LTD ORBK
10.86%
NOAH HOLDING NOAH
9.92%
SONIC FOUNDR SOFO
9.45%
VIPSHOP HOLD VIPS
9.20%
RENEWABLE EN REGI
8.98%

NYSE to Shed Stake in MCX India

by Zacks Equity Research

March 08, 2013 | Comments : 0 Recommended this article: (0)

This page is temporarily not available.  Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext.  9339.

In an effort to restructure its business operations, NYSE Euronext Inc. ( NYX - Analyst Report ) intends to vend of its 4.79% stake in India-based multi-commodity exchange – MCX Stock Exchange (MCX), according to Reuters. The company expects to earn about $45 million from the sale.

In Jun 2008, NYSE had bought about 5% holding in MCX for about $44 million. However, the MCX business is not generating healthy returns for NYSE due to weak market response from the investors.

Hence, the company has pegged to sell about 2.44 million shares that it owns in MCX between $18.4 and $18.8 per share. At the higher end, this sums to about $45 million. On Mar 7, the shares of MCX closed at about $18.85 in India.

The latest sale is an effort undertaken by NYSE to simplify its business by shedding off non-core assets, particularly in the wake of the ongoing merger deal with IntercontinentalExchange Inc. ( ICE - Analyst Report ) . NYSE may not want to repeat the mistake of being disliked by the regulators, which happened during the failed merger deal with Frankfurt-based Deutsche Boerse last year.

The company is looking forward to ward off all kinds of probable difficulties that could raise questions among regulators in the current deal with IntercontinentalExchange. Amid this, an inflated debt position and lack of any strong growth catalyst further impel NYSE to strategize its business operations as well as lower its operating and capital costs.

Moreover, the ongoing market volatility, currency fluctuations and intense global competition has been weighing on the trading volumes, a key revenue source for NYSE, over the past several quarters. Restricted top-line growth has also been nibbling into the earnings and margins of the company. The financial services technology sales are also experiencing a challenging period.

Although NYSE is yet to confirm reports on the sale of the MCX stake, we believe a business restructuring to concentrate on core efficiencies and retain market share in such operations appears a reasonable point of action for the company. A risky financial and operating leverage could also shake investor confidence, and call for an appropriate check and control processes instantaneously.

Others

While NYSE carries a Zacks Rank #3 (Hold), other outperformers of the financial sector include Moody’s Corp. ( MCO - Analyst Report ) , Fleetcor Tech Inc. ( FLT - Snapshot Report ) and Vantiv Inc. ( VNTV - Snapshot Report ) all ofwhich carry a Zacks Rank #1 (Strong Buy).

Email Print Share Rate Pos Rate Neg

Read/Post Comments (0) | Recommended this article (0)

Please login to Zacks.com or register to post a comment.

Zacks Research is Reported On:

Zacks Investment Research

is an A+ Rated BBB

Accredited Business.